AYAL Capital Advisors Ltd Invests $2.78 Million in Surgery Partners, Inc. $SGRY

AYAL Capital Advisors Ltd purchased a new stake in Surgery Partners, Inc. (NASDAQ:SGRY) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 125,000 shares of the company’s stock, valued at approximately $2,779,000. AYAL Capital Advisors Ltd owned 0.10% of Surgery Partners at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. PNC Financial Services Group Inc. lifted its stake in shares of Surgery Partners by 86.4% in the first quarter. PNC Financial Services Group Inc. now owns 1,169 shares of the company’s stock valued at $28,000 after buying an additional 542 shares in the last quarter. AlphaQuest LLC lifted its position in Surgery Partners by 112.0% in the 1st quarter. AlphaQuest LLC now owns 1,058 shares of the company’s stock valued at $25,000 after acquiring an additional 559 shares in the last quarter. California State Teachers Retirement System boosted its stake in Surgery Partners by 1.6% during the 2nd quarter. California State Teachers Retirement System now owns 65,091 shares of the company’s stock valued at $1,447,000 after purchasing an additional 1,021 shares during the last quarter. Police & Firemen s Retirement System of New Jersey boosted its stake in Surgery Partners by 7.2% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 17,582 shares of the company’s stock valued at $391,000 after purchasing an additional 1,176 shares during the last quarter. Finally, Empowered Funds LLC increased its holdings in Surgery Partners by 11.0% during the 1st quarter. Empowered Funds LLC now owns 12,853 shares of the company’s stock worth $305,000 after purchasing an additional 1,278 shares in the last quarter.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on SGRY shares. Royal Bank Of Canada cut their target price on Surgery Partners from $35.00 to $31.00 and set an “outperform” rating on the stock in a research report on Tuesday, November 11th. UBS Group cut their price objective on shares of Surgery Partners from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday, November 13th. Mizuho reduced their target price on shares of Surgery Partners from $28.00 to $22.00 and set an “outperform” rating for the company in a research note on Monday, November 17th. JPMorgan Chase & Co. dropped their price target on shares of Surgery Partners from $27.00 to $20.00 and set a “neutral” rating on the stock in a research report on Monday, November 24th. Finally, Benchmark reduced their price objective on shares of Surgery Partners from $35.00 to $30.00 and set a “buy” rating for the company in a research report on Tuesday, November 11th. Seven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $27.44.

Surgery Partners Price Performance

Shares of NASDAQ:SGRY opened at $15.63 on Friday. The company has a market capitalization of $2.02 billion, a P/E ratio of -11.49 and a beta of 1.93. The company’s 50-day moving average is $18.84 and its 200 day moving average is $21.07. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.72 and a current ratio of 1.88. Surgery Partners, Inc. has a fifty-two week low of $14.94 and a fifty-two week high of $26.16.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Monday, November 10th. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by ($0.06). Surgery Partners had a positive return on equity of 2.41% and a negative net margin of 5.21%.The firm had revenue of $821.50 million during the quarter, compared to analysts’ expectations of $823.55 million. During the same period in the prior year, the business earned $0.19 earnings per share. The business’s quarterly revenue was up 6.6% compared to the same quarter last year. On average, equities research analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.